Clinical Trial Update: Combined Patching-Atropine for Residual Amblyopia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combined patching and atropine for residual amblyopia was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amblyopia

Drugs mentioned

• atropine sulfate ophthalmic solution (atropine sulfate)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: TERMINATED | Results posted: 2011-03-23